Salvianolic Acid B improves cognitive impairment by inhibiting neuroinflammation and decreasing Aβ level in Porphyromonas gingivalis-infected mice.

Aging
Jianwei LiuQinfeng Sun

Abstract

Amyloid-β (Aβ) accumulation is one of the main pathological hallmarks of Alzheimer's disease (AD). Porphyromonas gingivalis (P. gingivalis), the pathogen of chronic periodontitis, could cause Aβ accumulation and was identified in the brain of AD patients. Salvianolic Acid B (SalB) has been proven to have the neuroprotective effect. Whether SalB could protect against P. gingivalis-induced cognitive impairment is still unknown. In this study, a P. gingivalis-infected mouse model was employed to study the neuroprotective role of SalB. The results showed that SalB (20 and 40 mg/kg) treatment for 4 weeks could shorten the escape latency and improve the percentage of spontaneous alternation in the P. gingivalis-infected mice. SalB inhibited the levels of reactive oxygen species and malondialdehyde, while increased the levels of antioxidative enzymes (superoxide dismutase and glutathione peroxidase). SalB decreased the levels of IL-1β and IL-6, increased the mRNA levels of bdnf and ngf in the brain of P. gingivalis-infected mice. In addition, SalB obviously decreased the level of Aβ. SalB elevated the protein expression of ADAM10, while downregulated BACE1 and PS1. SalB increased the protein expression of LRP1, while decreased RAGE. I...Continue Reading

References

Apr 3, 2003·Neuron·Flavio KamenetzRoberto Malinow
May 11, 2005·Neurology·S GilmanUNKNOWN AN1792(QS-21)-201 Study Team
Apr 26, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G M ShakedE H Koo
Dec 19, 2006·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Chang-Suo LiuJun-Tian Zhang
Feb 11, 2014·Asian Pacific Journal of Tropical Medicine·Ling XueYan-Hua Guo
Mar 26, 2014·Neuroscience Bulletin·Zhichun Chen, Chunjiu Zhong
Dec 11, 2014·Neurobiology of Aging·Angela R KamerMony J de Leon
Jul 16, 2015·Cellular and Molecular Neurobiology·Zhiyou CaiBin Zhao
Apr 30, 2016·Neural Regeneration Research·Zhe ZhuRui Li
May 27, 2016·Science Translational Medicine·Deepak Kumar Vijaya KumarRobert D Moir
Sep 3, 2016·BMC Complementary and Alternative Medicine·Dan LiRuichao Lin
Nov 27, 2016·Odontology·Miriam Puig-SillaJosé Manuel Almerich-Silla
Jan 7, 2017·Journal of Alzheimer's Disease : JAD·Eric Tönnies, Eugenia Trushina
Apr 18, 2017·Current Alzheimer Research·Siva Sundara Kumar DurairajanMin Li
Sep 9, 2017·Methods in Cell Biology·Changyi JiGail V W Johnson
Mar 20, 2018·Biochemical and Biophysical Research Communications·Yan HeHeng Du
Jun 7, 2019·Neurology·Gérard N Bischof, Heidi I L Jacobs
Sep 19, 2019·Brain : a Journal of Neurology·Francesco PanzaBruno P Imbimbo
Oct 9, 2019·Journal of Alzheimer's Disease : JAD·Ran NieYanmin Zhou
Dec 5, 2019·Journal of Alzheimer's Disease : JAD·Lee SchnaiderEhud Gazit

❮ Previous
Next ❯

Citations

May 4, 2021·Expert Review of Anti-infective Therapy·Ingar Olsen

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA
ELISA
electrophoresis

Software Mentioned

GraphPad Prism
SPSS

Related Concepts

Related Feeds

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.